Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

被引：182
|
作者：
Yuan, Xun [1 ]
Wu, Hua [1 ]
Han, Na [1 ]
Xu, Hanxiao [1 ]
Chu, Qian [1 ]
Yu, Shiying [1 ]
Chen, Yuan [1 ]
Wu, Kongming [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Bldg 303,1095 Jie Fang Ave, Wuhan 430030, Peoples R China
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2014年 / 7卷
基金：
美国国家科学基金会;
关键词：
Notch signaling; Epithelial-mesenchymal transition (EMT); Cancer stem cells (CSCs); Non-small-cell lung cancer (NSCLC); Gamma secretase inhibitor; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE INHIBITOR; CYCLIN D1; TGF-BETA; POOR-PROGNOSIS; TUMOR-GROWTH; STEM-CELLS; E-CADHERIN; IN-VITRO; PHASE-I;
D O I：
10.1186/s13045-014-0087-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Through epithelial-mesenchymal transition (EMT), cancer cells acquire enhanced ability of migration and invasion, stem cell like characteristics and therapeutic resistance. Notch signaling regulates cell-cell connection, cell polarity and motility during organ development. Recent studies demonstrate that Notch signaling plays an important role in lung cancer initiation and cross-talks with several transcriptional factors to enhance EMT, contributing to the progression of non-small cell lung cancer (NSCLC). Correspondingly, blocking of Notch signaling inhibits NSCLC migration and tumor growth by reversing EMT. Clinical trials have showed promising effect in some cancer patients received treatment with Notch1 inhibitor. This review attempts to provide an overview of the Notch signal in NSCLC: its biological significance and therapeutic application.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Novel Therapeutic Targets in Non-small Cell Lung Cancer
    Janku, Filip
    Garrido-Laguna, Ignacio
    Petruzelka, Lubos B.
    Stewart, David J.
    Kurzrock, Razelle
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1601 - 1612
  • [32] Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
    Sirhan, Zaid
    Alojair, Rawan
    Thyagarajan, Anita
    Sahu, Ravi P.
    PHARMACEUTICS, 2023, 15 (08)
  • [33] EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
    La Monica, Silvia
    CELLS, 2022, 11 (08)
  • [34] Therapeutic targeting of telomerase for non-small cell lung cancer
    Frink, Robin
    Spinola, Monica
    Wright, Woodring
    Schiller, Joan
    Shay, Jerry
    Minna, John
    CANCER RESEARCH, 2009, 69
  • [35] Targeting estrogen signaling pathways for therapeutic intervention in non-small cell lung cancer.
    Marquez, Diana C.
    Mah, Vei
    Goodglick, Lee
    Garbon, Hermes
    Weinberg, Olga
    Fishbein, Michael
    Chia, David
    Chen, Hsiao-Wang
    Dubinett, Steven
    Seligson, David
    Pietras, Richard
    CANCER RESEARCH, 2006, 66 (08)
  • [36] Novel therapeutic targets in non-small cell lung cancer
    Alamgeer, Muhammad
    Ganju, Vinod
    Watkins, D. Neil
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (03) : 394 - 401
  • [37] Wnt Signaling Pathway in Non-Small Cell Lung Cancer
    Stewart, David J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (01):
  • [38] Analysis of signaling network in non-small cell lung cancer
    Liu Wei
    Ye Fei
    Li Guanghu
    Wu Yong
    Wang Libo
    Glaser, Laurel
    Yin Guanghao
    Xue Menghua
    Zhu Dongshan
    Zhang, David Y.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S628 - S628
  • [39] Combination of biological therapies in non-small cell lung cancer
    Bianco, R
    Damiano, V
    Tortora, G
    ANNALS OF ONCOLOGY, 2006, 17 : 52 - 54
  • [40] EVOLUTION OF BIOLOGICAL THERAPIES IN NON-SMALL CELL LUNG CANCER
    White, Shane
    Pavlakis, Nick
    CANCER FORUM, 2008, 32 (03)
12345